Prognostic value of FOXQ1 in patients with malignant solid tumors: a meta-analysis

Figures & data

Figure 1 Selection flowchart of the meta-analysis.

Table 1 Main characteristics of all studies included in the meta-analysis

First author (year)	Patient source	Histology	Number of patients	Method	Positive (%)	HR estimation	Survival results
Xia et al^Citation16 Cohort I	China	HCC	690	IHC	54.5	HR and 95% CI: 1.27 (1.03–1.56)	Poor
Xia et al^Citation16 Cohort II	China	HCC	312	IHC	53.8	HR and 95% CI: 1.48 (1.09–2.01)	Poor
Zhan et al^Citation21	China	PC	83	IHC	41.0	HR and 95% CI: 1.856 (1.065–3.234)	Poor
Feng et al^Citation13	China	NSCLC	103	IHC	79.6	HR and 95% CI: 2.091 (1.009–4.332)	Poor
Liang et al^Citation19	China	GC	158	IHC	53.8	HR and 95% CI: 1.286 (0.746–2.248)	Poor
Zhang et al^Citation22	China	GC	60	IHC	63.3	HR and 95% CI: 1.942 (1.057–3.567)	Poor
Wang et al^Citation15	China	HCC	114	IHC	68.4	HR and 95% CI: 2.691 (1.364–5.309)	Poor

Abbreviations: CI, confidence interval; GC, gastric cancer; HR, hazard ratio; HCC, hepatocellular carcinoma; IHC, immunohistochemistry; NSCLC, non-small-cell lung cancer; PC, pancreatic cancer.

Figure 2 In subgroup analyses, forest plot of HR for the association of FOXQ1 expression with OS in patients with malignant solid tumors.

Abbreviations: CI, confidence interval; FOXQ1, forkhead box Q1; HCC, hepatocellular carcinoma; HR, hazard ratio; OS, overall survival.

Figure 3 Results of sensitivity analysis by omitting each study at a time.

Notes: Rows represent the results of meta-analysis of all studies except the omitted study named in that row. Omission of any study did not affect the whole estimate results significantly.
Abbreviation: CI, confidence interval.

XiaLHuangWTianDForkhead box Q1 promotes hepatocellular carcinoma metastasis by transactivating ZEB2 and VersicanV1 expressionHepatology201459395897324005989

 PubMed Web of Science ®Google Scholar

ZhanHXXuJWWangLWuDZhangGYHuSYFoxQ1 is a novel molecular target for pancreatic cancer and is associated with poor prognosisCurr Mol Med201515546947726122655

 PubMed Web of Science ®Google Scholar

FengJZhangXZhuHWangXNiSHuangJFoxQ1 overexpression influences poor prognosis in non-small cell lung cancer, associates with the phenomenon of EMTPLoS One201276e3993722761930

 PubMedGoogle Scholar

LiangSHYanXZWangBLIncreased expression of FOXQ1 is a prognostic marker for patients with gastric cancerTumour Biol20133452605260923609035

 PubMedGoogle Scholar

ZhangJLiuYZhangJFOXQ1 promotes gastric cancer metastasis through upregulation of SnailOncol Rep20163563607361327109028

 PubMedGoogle Scholar

WangWHeSJiJHuangJZhangSZhangYThe prognostic significance of FOXQ1 oncogene overexpression in human hepatocellular carcinomaPathol Res Pract2013209635335823623360

 PubMedGoogle Scholar